Lead integrated development and commercialization strategy for autoimmune CAR-T programs.
Establish lifecycle governance, decision frameworks, and cross-program coordination.
Partner with executive leadership to drive portfolio prioritization and investment decisions.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. The company is guided by core values including collaboration, clarity, and innovation, and is committed to transforming treatment for autoimmune disease.
Provide program management expertise and leadership for novel engineered T cell therapies, managing cross-functional development programs.
Drive execution against critical path activities, track milestones, and communicate risks to senior leadership.
Influence cross-functional stakeholders to align on priorities, resolve conflicts, and support governance forums.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases. It is a rapidly growing company driven by core values of innovation and collaboration.
Lead clinical development strategy and execution for CAR T-cell therapy trials in autoimmune diseases.
Oversee scientific content of protocols, regulatory documents, and clinical study reports.
Represent Clinical Development with cross-functional teams, KOLs, and external stakeholders.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases. It fosters a culture of collaboration, innovation, and accountability with a focus on transforming treatment paradigms.